Exenatide once weekly: sustained improvement in glycemic control and cardiometabolic measures through 3 years

BACKGROUND: Type 2 diabetes mellitus is a progressive metabolic disease necessitating therapies with sustained efficacy and safety over time. Exenatide once weekly (ExQW), an extended-release formulation of the glucagon-like peptide-1 receptor agonist exenatide, has demonstrated improvements in glyc...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: MacConell, Leigh, Pencek, Richard, Li, Yan, Maggs, David, Porter, Lisa
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2013
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3555554/
https://ncbi.nlm.nih.gov/pubmed/23358123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S35801
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker